About HiGlance
HiGlance is a Healthcare company. Pharmaceutical production and export of medicines for various health issues from India. The company has 386 employees. Its Indian entity Higlance Laboratories Private Limited reported revenue of βΉ75.98 Cr. HiGlance offers products and services including Pharmaceutical Products and Contract Manufacturing. Its focus areas include Pharmaceuticals, Drug Manufacturing, Antibiotic Production and Research and Development.
Company details
HiGlance is recognized as a leading producer and exporter of pharmaceutical products, with a wide range of medicines developed for treating infections, allergies, and metabolic disorders. The companys quality systems are certified under ISO 9001-2008, GMP, and WHO GMP, and products are aligned with international pharmacopeia standards. Participation in WHO programs for combating diseases is noted, while exports are facilitated through automated systems and representations in multiple countries. Information on the site is intended for specialists only.
- Employees 386
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website higlance.ru
- Legal Name Higlance Laboratories Pvt. Ltd
- Date of Incorporation 11 Jun, 2003
- Jurisdiction New Delhi, Delhi, India
- Indian entity revenue₹75.98 Cr
FY 2025 · +7% YoY
- Indian entity net profit₹6.26 Cr
FY 2025 · 8% margin
- Indian entity EBITDA₹11.94 Cr
FY 2025 · 16% margin
- Employee Count386
Associated legal entities of HiGlance
HiGlance operates through Higlance Laboratories Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Higlance Laboratories Private Limited CIN U24239DL2003PTC120847 | Active | 11 Jun 2003 | New Delhi, Delhi | ₹76.0 Cr | 386 | 3 | View details |
Products & Services of HiGlance
HiGlance offers a comprehensive portfolio of products and services, including Pharmaceutical Products and Contract Manufacturing.
Products for treating infections and other health conditions are manufactured and supplied by HiGlance
Services for pharmaceutical production are provided by HiGlance to meet external demands
Board of directors of Higlance Laboratories Private Limited (HiGlance)
Higlance Laboratories Private Limited is the primary company behind HiGlance. The board of Higlance Laboratories Private Limited currently have 3 directors; the longest-serving is Kalawati Devi, appointed in 2003. 5 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Kalawati Devi DIN 01657491 | Director | 11 Jun 2003 | 23 yrs 5 mo | Higlance Laboratories Private Limited |
| Ajay Singh DIN 01048028 | Whole-time director | 11 Jun 2003 | 23 yrs 5 mo | Higlance Laboratories Private Limited |
| Sanjay Kumar Singh DIN 01598183 | Managing Director | 11 Jun 2003 | 23 yrs 5 mo | Higlance Laboratories Private Limited |
Financials of HiGlance
Figures of Higlance Laboratories Private Limited, the primary company behind HiGlance, for FY 2025. Revenue was ₹75.98 Cr (+7% year on year). Net profit was ₹6.26 Cr (8% margin). EBITDA was ₹11.94 Cr (16% margin). Revenue has grown at a compounded annual rate of +8% over three years and +11% over five years.
- ₹75.98 CrRevenue · FY 2025 · +7% YoY
- ₹6.26 CrNet profit · 8% margin
- ₹11.94 CrEBITDA · 16% margin
- ₹6.00 CrPaid-up capital
- 386Employees (provident fund records)
- +8%Revenue CAGR, 3 years
- +11%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Higlance Laboratories Private Limited are on its company page.
Detailed financial statements for HiGlance
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about HiGlance
HiGlance has 386 employees.
The primary company behind HiGlance, Higlance Laboratories Private Limited, reported revenue of βΉ75.98 Cr for FY 2025, up 7% year on year.
HiGlance is recognized as a leading producer and exporter of pharmaceutical products, with a wide range of medicines developed for treating infections, allergies, and metabolic disorders. The companys quality systems are certified under ISO 9001-2008, GMP, and WHO GMP, and products are aligned with international pharmacopeia standards. Participation in WHO programs for combating diseases is noted, while exports are facilitated through automated systems and representations in multiple countries. Information on the site is intended for specialists only.
HiGlance offers Pharmaceutical Products and Contract Manufacturing.
HiGlance operates through Higlance Laboratories Private Limited.
The legal entities of HiGlance currently have 3 directors, including Kalawati Devi, Ajay Singh, Sanjay Kumar Singh.
